Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The activated hepatic stellate cell (HSC) is central to liver fibrosis as the major source of collagens I and III and the tissue inhibitors of metalloproteinase-1 (TIMP-1). During spontaneous recovery from liver fibrosis, there is a decrease of TIMP expression, an increase in collagenase activity, and increased apoptosis of HSC, highlighting a potential role for TIMP-1 in HSC survival. In this report, we use tissue culture and in vivo models to demonstrate that TIMP-1 directly inhibits HSC apoptosis. TIMP-1 demonstrated a consistent, significant, and dose-dependent antiapoptotic effect for HSC activated in tissue culture and stimulated to undergo apoptosis by serum deprivation, cycloheximide exposure, and nerve growth factor stimulation. A nonfunctional mutated TIMP-1 (T2G mutant) in which all other domains are conserved did not inhibit apoptosis, indicating that inhibition of apoptosis was mediated through MMP inhibition. Synthetic MMP inhibitors also inhibited HSC apoptosis. Studies of experimental liver cirrhosis demonstrated that persistent expression of TIMP-1 mRNA determined by PCR correlated with persistence of activated HSC quantified by alpha smooth muscle actin staining, while in fibrosis, loss of activated HSC correlated with a reduction in TIMP-1 mRNA. We conclude that TIMP-1 inhibits apoptosis of activated HSC via MMP inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concurrently, tissue inhibitors of metalloproteases (TIMPs) produced by HSCs are increased in experimental fibrosis, which could block the activity of their cognate enzymes and also prevent apoptosis of activated HSCs (278, 279).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [278]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
CD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Self-citationHepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G., & Reynolds, J. J. (1985) · Nature · doi:10.1038/318066a0 · Cited by 689
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
Portmann, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80245-6 · Cited by 549
Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Research works printed but not linked: 6
- Milani, 1992, Hepatology, 16, 186
- Vyas, 1995, 5, 399
- Saile, 1997, Am. J. Pathol., 151, 1265
- Li, 1999, Cancer Res., 59, 6267
- Ree, 1997, Clin. Cancer Res., 3, 1623
- Trim, 2000, Hepatology, 32, 183
Cited by
Items 101–200 of 431
Hepatic steatosis and fibrosis: Non-invasive assessment
Karanjia, R. N., Crossey, M. M. E., Cox, I. J., Fye, H. K. S., Njie, R., Goldin, R. D., & Taylor-Robinson, S. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i45.9880 · Cited by 98
TIMP-1 as a tumor marker in breast cancer – An update
Würtz, S. Ø., Würtz, S. Ø., Schrohl, A., Mouridsen, H. T., & Brünner, N. (2008) · Acta Oncologica · doi:10.1080/02841860802022976 · Cited by 95
“Controversy still exists as to how TIMP-1 regulates apoptosis and both MMP-dependent [14] and MMP-independent mechanisms [11 13,29] have been proposed (reviewed in details elsewhere [39,40]).”
Wang, Q., Dai, X., Yang, W., Wang, H., Zhao, H., Yang, F., Yang, Y., Li, J., & Lv, X. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.012 · Cited by 102
Mac the knife? Macrophages– the double-edged sword of hepatic fibrosis
Friedman, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523928 · Cited by 95
“(13), pinpointing the molecular signaling mechanisms that mediate SDF-1 effects on primitive”
BackgroundTissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival
LAMBERT, E., BOUDOT, C., KADRI, Z., SOULA-ROTHHUT, M., SOWA, M.-L., MAYEUX, P., HORNEBECK, W., HAYE, B., & PETITFRERE, E. (2003) · Biochemical Journal · doi:10.1042/bj20030187 · Cited by 94
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
“apoptosis and inhibits the MMPs functions (192), favoring the partial degradation of ECM (55).”
Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons
Tan, H. K., Heywood, D. J., Ralph, G. S., Bienemann, A. S., Baker, A. H., & Uney, J. B. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(02)00024-6 · Cited by 94
Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis
Czaja, A. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12592 · Cited by 92
Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement
Suk, K. T., & Kim, D. J. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.607 · Cited by 100
Advances in antifibrotic therapy
Ghiassi–Nejad, Z., & Friedman, S. L. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.6.803 · Cited by 88
Fibrosis and Cirrhosis Reversibility – Molecular Mechanisms
Gieling, R. G., Burt, A. D., & Mann, D. A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.001 · Cited by 92
“In vitro studies confirmed that TIMP-1 suppresses HM apoptosis via inhibition of MMP activities.(31) Based on these discoveries, Roderfeld and colleagues(93) recently demonstrated the potential for an innovative and promising therapeutic strategy in which the highly elevated levels of TIMP-1 in the diseased liver are…”
BackgroundInfluentialMatrix Metalloproteinase Gene Delivery for Liver Fibrosis
Iimuro, Y., & Brenner, D. A. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9311-7 · Cited by 91
Hornebeck, W., Lambert, E., Petitfrere, E., & Bernard, P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.022 · Cited by 82
Wang, H., Lafdil, F., Wang, L., Yin, S., Feng, D., & Gao, B. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-14 · Cited by 80
“Discussions Although the profibrotic effect of TIMP-1 mainly produced by HSCs has been well documented [15,19], we reveal here for the first time an unexpected hepatoprotective feature of TIMP-1 and contribution of hepatocytes to TIMP-1 production during CCl4-induced liver injury.”
BackgroundInfluentialA role for thrombin in liver fibrosis
Gillibert-Duplantier, J., Dubuisson, L., Dugot‐Senant, N., Freyburger, G., Laurendeau, I., Herbert, J.-M., Desmoulière, A., & Rosenbaum, J. (2004) · Gut · doi:10.1136/gut.2003.032136 · Cited by 80
“in bile duct ligated rats, where treatment with pentoxifylline had only a limited effect on liver fibrosis although it profoundly decreased expression of collagen I mRNA, most likely because it increased TIMP-1 expression. The deleterious effects of TIMP-1 may be related not only to its inhibitory effect on matrix deg…”
BackgroundPerumal, M. K., Perumal, N., Samidurai, M., Devaraj, H., & NiranjaliDevaraj, S. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.008 · Cited by 86
Molecular Pathogenesis of Alcohol‐Induced Hepatic Fibrosis
Siegmund, S., & Brenner, D. A. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000189275.97419.58 · Cited by 88
Sørensen, N. M., Byström, P., Christensen, I. J., Berglund, A., Nielsen, H. J., Brünner, N., & Glimelius, B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0186 · Cited by 77
TIMP-1 via TWIST1 Induces EMT Phenotypes in Human Breast Epithelial Cells
D'Angelo, R. C., Liu, X.-W., Najy, A. J., Jung, Y. S., Won, J. J., Chai, K. X., Fridman, R. A., & Kim, H.-R. C. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0105 · Cited by 78
Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities
Manka, P., Zeller, A., & Syn, W.-K. (2019) · Drugs · doi:10.1007/s40265-019-01126-9 · Cited by 76
Schrohl, A., Gelder, M. E. M., Holten-Andersen, M., Christensen, I. J., Look, M. P., Mouridsen, H. T., Brünner, N., & Foekens, J. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0950 · Cited by 75
“It should be mentioned, however, that in certain other cell types, this ability of TIMP-1 to inhibit apoptosis does seem to depend on its matrix metalloproteinase inhibitory function (11).”
BackgroundMolecular Mechanisms of Alcohol-Induced Hepatic Fibrosis
Siegmund, S. V., Dooley, S., & Brenner, D. A. (2005) · Digestive Diseases · doi:10.1159/000090174 · Cited by 75
“Rats treated with the TIMP-1 antibody had reduced levels of liver fibrosis compared to controls, as determined by histological analysis and hydroxyproline content. In addition, the antibody caused reductions in MMP-2 activity and a-SMA expression. We also observed a reduction in the number of activated HSCs. This was…”
MethodAoki, M., Miyake, K., Ogawa, R., Dohi, T., Akaishi, S., Hyakusoku, H., & Shimada, T. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.396 · Cited by 74
“This is consistent with an earlier report that TIMP-1 exerts anti-apoptotic effects in various cell types (Murphy et al., 2002).”
ResultAgarwal, K., Czaja, A. J., & Donaldson, P. T. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00794.x · Cited by 86
The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis
Liu, L., Yannam, G. R., Nishikawa, T., Yamamoto, T., Basma, H., Ito, R., Nagaya, M., Dutta-Moscato, J., Stolz, D. B., Duan, F., et al. (2012) · Hepatology · doi:10.1002/hep.24815 · Cited by 74
“This issue is critical because interventions in animals have been shown to improve hepatic fibrosis and reverse cirrhosis.(1,26-28) Another potential consequence of this work might be that injured and modestly functioning organs may serve as an untapped source of cells that could potentially be used for cell therapy i…”
BackgroundMolecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Wang, F.-D., Zhou, J., & Chen, E.-Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.787748 · Cited by 71
Kim, E.-M., Shin, E.-J., Choi, J. H., Son, H. J., Park, I.-S., Joh, T. H., & Hwang, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093799 · Cited by 72
Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis
Simon, F., Bergeron, D. M., Larochelle, S., Lopez‐Vallé, C. A., Genest, H., Armour, A. D., & Moulin, V. J. (2011) · Burns · doi:10.1016/j.burns.2011.09.001 · Cited by 72
“[33] Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, et al.”
BackgroundStrup-Perrot, C., Mathé, D., Linard, C., Violot, D., Milliat, F., François, A., Bourhis, J., & Vozenin, M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00088.2004 · Cited by 85
“In vivo activation of pro-MMPs is mostly mediated through the plasminogen-plasmin cascade and by MMPs themselves (18, 30).”
BackgroundThe interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH
Barbero-Becerra, V. J., Giraudi, P. J., Chávez-Tapia, N. C., Uribe, M., Tiribelli, C., & Rosso, N. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.07.010 · Cited by 71
TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice
Thiele, N. D., Wirth, J. W., Steins, D., Koop, A. C., Ittrich, H., Lohse, A. W., & Kluwe, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00671-1 · Cited by 79
Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?
Tu, T., Calabro, S. R., Lee, A., Maczurek, A. E., Budzinska, M. A., Warner, F. J., McLennan, S. V., & Shackel, N. A. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13065 · Cited by 71
Mishra, A., Paul, S., & Swarnakar, S. (2011) · Biochimie · doi:10.1016/j.biochi.2011.02.007 · Cited by 72
Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis
Ali, G., Mohsin, S., Khan, M., Nasir, G. A., Shams, S., Khan, S. N., & Riazuddin, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-75 · Cited by 70
“These factors activate HSCs which upon stimulation lose retinoid storing ability and transform into myofibroblasts [26,27].”
BackgroundA New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons
Ould-yahoui, A., Tremblay, E., Sbai, O., Ferhat, L., Bernard, A., Charrat, E., Gueye, Y., Lim, N. H., Brew, K., Risso, J.-J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008289 · Cited by 69
“We have combined a systematic morphometric analysis of cultured cortical neurons with the use of pseudophosphinic synthetic MMP inhibitors [16,23], mouse recombinant full length TIMP-1, and recombinant WT and mutated inactive forms of the TIMP-1 Nterminal domain [24] previously used to demonstrate the determinant role…”
MethodTIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis
Davidsen, M. L., Würtz, S., Rømer, M. U., Sørensen, N. M., Johansen, S. K., Christensen, I. J., Larsen, J. K., Offenberg, H., Brünner, N., & Lademann, U. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603378 · Cited by 68
“…increased sensitivity to chemotherapeutic drugs TIMP-1 has been demonstrated to inhibit apoptosis induced by various stimuli in several different types of cells (Guedez et al, 1998; Li et al, 1999; Murphy et al, 2002; Lee et al, 2003; Liu et al, 2003, 2005; Boulday et al, 2004; Murphy et al, 2004).”
BackgroundTargeted treatments for cirrhosis
Fallowfield, J. A., & Iredale, J. P. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.423 · Cited by 68
“In addition, TIMP-1 has been shown to inhibit apoptosis of some cell types including HSCs, and may therefore promote and perpetuate fibrosis by being antiapoptotic for activated HSCs [13].”
BackgroundSelf-citationLee, S., Yoo, H. J., Bae, Y. S., Kim, H. J., & Lee, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.050 · Cited by 68
Lieber, C. S., Weiss, D. G., Paronetto, F., & for the Veterans Affairs Cooperative Study 391 Group (2008) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00664.x · Cited by 66
“It inhibits the activity of MMPs and prevents stellate cells apoptosis (Murphy et al., 2002).”
BackgroundRamezani-Moghadam, M., Wang, J., Ho, V., Iseli, T. J., Alzahrani, B., Xu, A., Van der Poorten, D., Qiao, L., George, J., & Hebbard, L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.598011 · Cited by 65
“Although TIMP-1 has been shown to inhibit apoptosis in HSCs (22), we next evaluated apoptosis and proliferation in the context of adiponectin induced TIMP-1.”
BackgroundInvolvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells
Ikeda, H., Nagashima, K., Yanase, M., Tomiya, T., Arai, M., Inoue, Y., Tejima, K., Nishikawa, T., Omata, M., Kimura, S., et al. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00039.2003 · Cited by 66
Taube, M. E., Liu, X.-W., Fridman, R. A., & Kim, H.-R. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209336 · Cited by 66
“…human breast cell lines and mammary epithelial cells as well as in transgenic mice (Alexander et al., 1996; Guedez et al., 1998a, b; Li et al., 1999; Murphy et al., 2002; Yoshiji et al., 2002; Lee et al., 2003; Liu et al., 2003, 2005), conflicting data has been reported regarding TIMP-1’s role in…”
BackgroundSantosh, N., Windsor, L. J., Mahmoudi, B. S., Li, B., Zhang, W., Chernoff, E. A. G., Rao, N., Stocum, D. L., & Song, F. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22503 · Cited by 60
Chan, Y.-T., Wang, N., Tan, H. Y., Li, S., & Feng, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00548 · Cited by 66
“Tissue inhibitors of metalloproteinase 1 (TIMP-1) and TGFb also promote antiapoptotic signals and survival of HSCs (Murphy et al., 2002).”
BackgroundEllinger-Ziegelbauer, H. C., Adler, M., Amberg, A., Brandenburg, A., Callanan, J. J., Connor, S. C., Fountoulakis, M., Gmuender, H., Gruhler, A., Hewitt, P. G., et al. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.022 · Cited by 61
“As HSCs are central mediators of hepatic fibrosis (Murphy et al., 2002), it is interesting to note that these genes were also found to be increased after treatment with 14SC, suggesting that activation of HSCs and hepatic fibrosis may develop after prolonged treatment.”
BackgroundOverexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Yamada, T., Oshima, T., Yoshihara, K., Tamura, S., Kanazawa, A., Inagaki, D., Yamamoto, N., Sato, T., Fujii, S., Numata, K., et al. (2010) · PubMed · Cited by 61
Melgar-Lesmes, P., Luquero, A., Parra-Robert, M., Mora, A., Ribera, J., Edelman, E. R., & Jiménez, W. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02498 · Cited by 61
Fukushima, M., Nakamuta, M., Kohjima, M., Kotoh, K., Enjoji, M., Kobayashi, N., & Nawata, H. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01142.x · Cited by 60
“Furthermore, TIMP-1 has been reported to regulate cell growth and apoptosis independently of the inhibition of matrix degradation, and to inhibit apoptosis of activated HSCs via MMP inhibition (40).”
BackgroundInflammation, Damage Repair and Liver Fibrosis - Role of Cytokines and Different Cell Types
Saile, B., & Ramadori, G. P. (2007) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2006-927395 · Cited by 60
Costa, P. M., Chicano‐Gálvez, E., López‐Barea, J., DelValls, T. Á., & Costa, M. H. (2010) · Environmental Pollution · doi:10.1016/j.envpol.2010.07.030 · Cited by 59
Hartland, S. N., Murphy, F. R., Aucott, R. L., Abergel, A., Zhou, X., Waung, J. A., Patel, N., Bradshaw, C., Collins, J. E., Mann, D. A., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02070.x · Cited by 58
“Previous work by our group has used cycloheximide for the induction of HSC apoptosis (40).”
MethodInfluentialSelf-citationTakahashi, M., Saito, H., Higashimoto, M., & Hibi∥, T. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00065.x · Cited by 59
The effect of taurine treatment on oxidative stress in experimental liver fibrosis
Mas, M. R. (2004) · Hepatology Research · doi:10.1016/j.hepres.2003.11.012 · Cited by 59
Atta, H. M., Elrehany, M. A., Hammam, O. A., Abdelghany, H. M., Ramzy, M. M., Roderfeld, M., Roeb, E., Al-Hendy, A., Abdelraheim, S. R., Allam, H. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112384 · Cited by 57
“Previous reports demonstrated that TIMP-1 attenuates spontaneous resolution of liver fibrosis by the combination of a net reduction of the MMP activity and suppression of apoptosis in activated hepatic stellate cells (HSCs) [7,8].”
BackgroundContribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure
Yan, C., Zhou, L., & Han, Y. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01775.x · Cited by 54
“Additionally, tissue inhibitor of metalloproteinase 1, the tissue inhibitor of MMPs, was shown to attenuate apoptosis of activated HSCs (42).”
BackgroundOsteopontin delays resolution of liver fibrosis
Leung, T.-M., Wang, X., Kitamura, N., Fiel, M. I., & Nieto, N. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.104 · Cited by 55
Recent advances in the pathogenesis and diagnosis of liver fibrosis
Torok, N. J. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2181-x · Cited by 61
“TIMP-1 levels have been shown to decrease with apoptosis of myofi broblasts.(54) On the other hand, stimulation of TIMP-1 activity is associated with decreased apoptosis of myofi broblasts(55) and activation of NF-κB.”
BackgroundGiannone, F. A., Baldassarre, M., Domenicali, M., Zaccherini, G., Trevisani, F., Bernardi, M., & Caraceni, P. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.191 · Cited by 57
“Finally, as during fibrogenesis, it can be anticipated that the leading role to fibrosis reabsorption would be performed by TIMP-1 expression, the fall of which would unmasks the MMP activity.(16,39,41)”
BackgroundDelivery and Targeting of miRNAs for Treating Liver Fibrosis
Kumar, V., & Mahato, R. I. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1497-x · Cited by 57
Reversibility of cirrhosis in chronic hepatitis B
Malekzadeh, R., Mohamadnejad, M., Rakhshani, N., Nasseri‐Moghaddam, S., Merat, S., Tavangar, S. M., & Sohrabpour, A. A. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00066-7 · Cited by 54
Tissue remodelling in liver diseases.
Giannelli, G., Quaranta, V., & Antonaci, S. (2003) · PubMed · doi:10.14670/hh-18.1267 · Cited by 53
Smart, D. E., Green, K., Oakley, F., Weitzman, J. B., Yaniv, M., Reynolds, G., Mann, J., Millward-Sadler, H., & Mann, D. A. (2006) · Hepatology · doi:10.1002/hep.21436 · Cited by 52
Valva, P., Casciato, P. C., Carrasco, J. M. D., Gadano, A. C., Galdame, O., Galoppo, M. C., Müllen, E., Matteo, E. D., & Preciado, M. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023218 · Cited by 59
“Tissue inhibitor of matrix metalloprotein inhibitor-1 (TIMP-1) protects collagen from MMP fibrolysis and also inhibits the apoptosis of HSC [49].”
BackgroundInfluentialThirupathi, A., Silveira, P., Nesi, R. T., & Pinho, R. A. (2016) · Human & Experimental Toxicology · doi:10.1177/0960327116638727 · Cited by 56
“The profibrogenic effects of TIMP-1 are thought to be mediated via preventing collagen degradation through inhibition of MMPs and protecting against activated HSC death.(12) It is believed that activated HSCs and Kupfer cells are the major sources for TIMP-1 production during liver injury.”
BackgroundMunsterman, I. D., Kendall, T. J., Khelil, N., Popa, M. O., Lomme, R. M. L. M., Drenth, J. P. H., & Tjwa, E. T. T. L. (2018) · Histopathology · doi:10.1111/his.13665 · Cited by 57
“HSCs display several collagen receptors, such as integrins, that receive cytokine signals [notably transforming growth factor (TGF)-b] from ECM components, which induce differentiation and proliferation of HSCs to maintain a profibrogenic phenotype.3,7 TIMPs have the ability to inhibit programmed cell death of HSCs.33…”
BackgroundLambert, E., Bridoux, L., Devy, J., Dassé, E., Sowa, M.-L., Duca, L., Hornebeck, W., Martiny, L., & Petitfrere, E. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.017 · Cited by 58
Antifibrotics in chronic liver disease: tractable targets and translational challenges
Ramachandran, P., & Henderson, N. C. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30110-8 · Cited by 50
Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis
Nie, Q.-H., Duan, G.-R., Luo, X.-D., Xie, Y.-M., Luo, H., Zhou, Y.-X., & Pan, B.-R. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i1.86 · Cited by 49
Cell-specific Gene Expression in Patients with Usual Interstitial Pneumonia
Kelly, M. M., Leigh, R., Gilpin, S. E., Cheng, E., Martin, G. E. M., Radford, K., Cox, G., & Gauldie, J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1648oc · Cited by 52
Regulation of Tissue Inhibitor of Metalloproteinase 1 Gene Transcription by RUNX1 and RUNX2
Bertrand-Philippe, M., Ruddell, R. G., Arthur, M. J. P., Thomas, J., Mungalsingh, N., & Mann, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311804200 · Cited by 49
Self-citationDuval, F., Moreno-Cuevas, J. E., González‐Garza, M. T., Rodriguez-Montalvo, C. A., & Cruz‐Vega, D. E. (2014) · Advances in Pharmacological Sciences · doi:10.1155/2014/373295 · Cited by 49
Sørensen, N. M., Sørensen, I. V., Würtz, S. Ø., Schrohl, A., Dowell, B. L., Davis, G. J., Christensen, I. J., Nielsen, H. J., & Brünner, N. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701878163 · Cited by 50
“[64] Murphy FR, Issa R, Zhou XY, Ratnarajah S, Nagase H,”
BackgroundExtracellular matrix remodeling in 3D: implications in tissue homeostasis and disease progression
Ford, A. J., & Rajagopalan, P. (2018) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1503 · Cited by 49
Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats
Huang, Y. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i9.1386 · Cited by 49
Fibrogenic cell reversion underlies fibrosis regression in liver
Friedman, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206645109 · Cited by 48
“Does softening of the ECM promote stellate cell apoptosis, reversion, or both? Does the relative expression of tissue inhibitors of metalloproteinases, which are determinants of stellate cell survival (14), also influence stellate cell reversion? By showing the capacity of stellate cells to engraft in liver and contri…”
BackgroundDrug choices in autoimmune hepatitis: Part B – nonsteroids
Czaja, A. J. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.38 · Cited by 49
Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C
Neuman, M. G., Schmilovitz‐Weiss, H., Hilzenrat, N., Bourlière, M., Marcellin, P., Trepo, C., Mazulli, T., Moussa, G., Patel, A. P., Baig, A. A., et al. (2012) · International Journal of Hepatology · doi:10.1155/2012/231210 · Cited by 51
“It inhibits the activity of MMPs and prevents stellate cells apoptosis [57].”
BackgroundMurphy, F. R., Waung, J. A., Collins, J. E., Arthur, M. J. P., Nagase, H., Mann, D. A., Benyon, R. C., & Iredale, J. P. (2004) · Comparative Hepatology · doi:10.1186/1476-5926-2-s1-s8 · Cited by 46
“Inhibition of HSC apoptosis by TIMP-1 has previously been shown to be due to its action of MMP inhibition [4].”
Self-citationResolving fibrosis in the diseased liver: Translating the scientific promise to the clinic
Muddu, A. K., Guha, I. N., Elsharkawy, A. M., & Mann, D. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.006 · Cited by 55
Miele, L., Forgione, A., Torre, G. L., Vero, V., Cefalo, C., Racco, S., Vellone, V. G., Vecchio, F. M., Gasbarrini, A., Rapaccini, G. L., et al. (2009) · Translational research · doi:10.1016/j.trsl.2009.06.007 · Cited by 46
Zhang, X., Feng, M., Liu, X., Bai, L., Kong, M., Chen, Y., Zheng, S., Liu, S., Wan, Y. Y., Duan, Z., et al. (2015) · Translational research · doi:10.1016/j.trsl.2015.10.008 · Cited by 47
Ding, Y., Sun, X., Chen, Y., Deng, Y., & Qian, K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.005 · Cited by 50
Pines, M. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.1.11 · Cited by 51
Targeting the stromal microenvironment in chronic inflammation
FILER, A., PITZALIS, C., & BUCKLEY, C. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.007 · Cited by 45
“High expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) by stellate cells/myofibroblasts appears to maintain their survival and inhibit degradation of matrix [40].”
BackgroundMatrix Metalloproteinases and Their Inhibitors
Campana, L., & Iredale, J. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00007-5 · Cited by 45
Self-citationKazemi, A., Fathy, M., Jahanian, A., Khanali, J., Ostadi, Y., Babajani, A., Tayebi, T., & Niknejad, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118457 · Cited by 64
Tang, Y. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3487-6 · Cited by 46
“TIMP-1 is also produced by Kupffer cells and hepatocytes especially in early stages of liver injury [102, 106–108], plays a putative role in tissue fibrosis [104, 109], and is also capable of inhibiting programmed cell death of HSCs, mediated via inhibition of pro-MMP activation and MMP activity [110, 111].”
BackgroundThorsen, S. B., Christensen, S. L., Würtz, S. Ø., Lundberg, M., Nielsen, B. S., Vinther, L., Knowles, M., Gee, N., Fredriksson, S., Möller, S., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-598 · Cited by 44
“The observed association between high TIMP-1 levels and poor prognosis may be explained by the other functions that have been disclosed for TIMP-1: influence on cell growth [18,19], angiogenesis [20-22], apoptosis independently of its MMP-inhibitory functions [23-26], and on epithelial-mesenchymal transition [27].”
BackgroundTIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2
Nalluri, S., Ghoshal-Gupta, S., Kutiyanawalla, A., Gayatri, S., Lee, B. R., Jiwani, S. S., Rojiani, A. M., & Rojiani, M. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137673 · Cited by 45
“The signaling feedback loop that appears to be functional between TIMP-1 and Bcl-2 is indeed striking; therefore we sought to identify a direct interaction between TIMP1 and Bcl-2, and have shown that immunoprecipitation of Bcl-2 coimmunoprecipitates TIMP1.”
BackgroundInfluentialTIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury
Duarte, S. M., Hamada, T., Kuriyama, N., Busuttil, R. W., & Coito, A. J. (2012) · Hepatology · doi:10.1002/hep.25710 · Cited by 43
Action mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in rats
Mu, Y., Liu, P., Du, G.-L., Du, J.-X., Wang, G., Aihua, L., Wang, L., & Li, F. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.09.032 · Cited by 44
Henkel, C., Roderfeld, M., Weiskirchen, R., Berres, M., Hillebrandt, S., Lammert, F., Meyer, H. E., Stühler, K., Graf, J., & Roeb, E. (2006) · PROTEOMICS · doi:10.1002/pmic.200600580 · Cited by 43
microRNA-222 modulates liver fibrosis in a murine model of biliary atresia
Shen, W.-J., Dong, R., Chen, G., & Zheng, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.065 · Cited by 42
“Research has shown that the Akt signaling pathway inhibited apoptosis in HSC [16] and stimulated HSC proliferation [17].”
BackgroundFowell, A. J., Collins, J. E., Duncombe, D. R., Pickering, J. A., Rosenberg, W. M., & Benyon, R. C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.009 · Cited by 45
Würtz, S. Ø., M⊘ller, S., Mouridsen, H. T., Hertel, P. B., Friis, E., & Brünner, N. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700305-mcp200 · Cited by 42
Genesis of hepatic fibrosis and its biochemical markers
Das, S. K., & Vasudevan, D. M. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701668516 · Cited by 45
“For example, levels of MMP-1, the most efficient type 1 collagenase in vitro, are not increased during resolution of liver fibrosis, whereas TIMP-1 clearance is associated with apoptosis of activated stellate cells [66].”
BackgroundPerugorria, M. J., Murphy, L. B., Fullard, N., Chakraborty, J. B., Vyrla, D., Wilson, C. L., Oakley, F., Mann, J., & Mann, D. A. (2012) · Hepatology · doi:10.1002/hep.26108 · Cited by 48
Cong, M., Liu, T., Wang, P., Xu, F., Yang, A., Bai, Y., Peng, Z., Wu, P., Tong, X., Chen, J., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.036 · Cited by 44
Boulday, G., Fitau, J., Coupel, S., Soulillou, J., & Charreau, B. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.004 · Cited by 41
Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy
Omar, R., Yang, J., Liu, H., Davies, N. M., & Gong, Y. (2016) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2016_6 · Cited by 44
Metadata
- Authors
- Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H.
- Affiliations
- University of Southampton (GB)
- Imperial College London (GB)
- Corresponding author
- Murphy, Frank R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 13
- Pages
- 11069-11076
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2164407945
- Cited by
- 432
- References
- 42
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 19 · 2012: 20
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6800 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- TIMP-1, hepatic stellate cells, apoptosis, matrix metalloproteinase inhibition, liver fibrosis, liver cirrhosis, alpha-smooth muscle actin, collagenase, serum deprivation, cycloheximide, nerve growth factor, TIMP-1 mRNA expression
- MeSH terms
- Animals, Cell Division, Cells, Cultured, Cycloheximide, Humans, Liver, Liver Cirrhosis, Apoptosis, Tissue Inhibitor of Metalloproteinase-1, Caspases, In Situ Nick-End Labeling, Rats, Caspase 3, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.